Your browser doesn't support javascript.
loading
Two predominant molecular subtypes of spinal meningioma: thoracic NF2-mutant tumors strongly associated with female sex, and cervical AKT1-mutant tumors originating ventral to the spinal cord.
Hua, Lingyang; Alkhatib, Majd; Podlesek, Dino; Günther, Leila; Pinzer, Thomas; Meinhardt, Matthias; Zeugner, Silke; Herold, Sylvia; Cahill, Daniel P; Brastianos, Priscilla K; Williams, Erik A; E Clark, Victoria; Shankar, Ganesh M; Wakimoto, Hiroaki; Ren, Leihao; Chen, Jiawei; Gong, Ye; Schackert, Gabriele; Juratli, Tareq A.
Afiliação
  • Hua L; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. lyhua15@fudan.edu.cn.
  • Alkhatib M; Department of Neurosurgery, Carl Gustav Carus University Hospital, TU Dresden, Dresden, Germany.
  • Podlesek D; Department of Neurosurgery, Carl Gustav Carus University Hospital, TU Dresden, Dresden, Germany.
  • Günther L; Department of Neurosurgery, Carl Gustav Carus University Hospital, TU Dresden, Dresden, Germany.
  • Pinzer T; Department of Neurosurgery, Carl Gustav Carus University Hospital, TU Dresden, Dresden, Germany.
  • Meinhardt M; Department for Pathology, Carl Gustav Carus University Hospital, TU Dresden, Dresden, Germany.
  • Zeugner S; Department for Pathology, Carl Gustav Carus University Hospital, TU Dresden, Dresden, Germany.
  • Herold S; Department for Pathology, Carl Gustav Carus University Hospital, TU Dresden, Dresden, Germany.
  • Cahill DP; Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases Dresden (NCT/UCC), Dresden, Germany.
  • Brastianos PK; Department of Neurosurgery, Translational Neuro-Oncology Laboratory, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Williams EA; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • E Clark V; Department of Neurosurgery, Translational Neuro-Oncology Laboratory, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Shankar GM; Department of Neurosurgery, Translational Neuro-Oncology Laboratory, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Wakimoto H; Department of Neurosurgery, Translational Neuro-Oncology Laboratory, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Ren L; Department of Neurosurgery, Translational Neuro-Oncology Laboratory, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Chen J; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Gong Y; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Schackert G; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Juratli TA; Department of Neurosurgery, Carl Gustav Carus University Hospital, TU Dresden, Dresden, Germany.
Acta Neuropathol ; 144(5): 1053-1055, 2022 11.
Article em En | MEDLINE | ID: mdl-35943573
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Medula Espinal / Neoplasias Meníngeas / Meningioma Tipo de estudo: Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Medula Espinal / Neoplasias Meníngeas / Meningioma Tipo de estudo: Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article